These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 11848330)
1. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. Amarapurkar D; Dhorda M; Kirpalani A; Amarapurkar A; Kankonkar S J Assoc Physicians India; 2001 Oct; 49():983-5. PubMed ID: 11848330 [TBL] [Abstract][Full Text] [Related]
2. Do different hepatitis C virus genotypes behave differently? Amarapurkar DN; Patel ND; Rane P; Kamani P Trop Gastroenterol; 2007; 28(3):99-104. PubMed ID: 18383996 [TBL] [Abstract][Full Text] [Related]
3. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368 [TBL] [Abstract][Full Text] [Related]
4. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
5. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China. You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881 [TBL] [Abstract][Full Text] [Related]
6. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Bressler BL; Guindi M; Tomlinson G; Heathcote J Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715 [TBL] [Abstract][Full Text] [Related]
8. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588 [TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
10. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area. Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity]. Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Rosen HR; McHutchison JG; Conrad AJ; Lentz JJ; Marousek G; Rose SL; Zaman A; Taylor K; Chou S Am J Gastroenterol; 2002 Mar; 97(3):714-20. PubMed ID: 11922568 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587 [TBL] [Abstract][Full Text] [Related]
15. Ribavirin in the treatment of hepatitis C. Abonyi ME; Lakatos PL Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084 [TBL] [Abstract][Full Text] [Related]
16. [Study on HCV genotypes in different clinical types of hepatitis C patients in Shenyang area]. Huang F; Cai C; Zhao G Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):64-7. PubMed ID: 12759958 [TBL] [Abstract][Full Text] [Related]
17. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin. Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124 [TBL] [Abstract][Full Text] [Related]
18. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism. Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825 [TBL] [Abstract][Full Text] [Related]
19. [HCV genotypes. Liver histopathology and immunologic profile in four groups of patients]. De Carvalho A; Martinho A; Leitão J; Cipriano MA; Coimbra H; Porto A Acta Med Port; 2000; 13(3):67-75. PubMed ID: 11026142 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological aspects of the genotype of hepatitis C virus. Xu B; Lu P; Zhu M Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):148-50. PubMed ID: 11503047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]